Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification

Journal of Clinical Microbiology

Volumn 46, Issue 8, 2008, Pages 2665-2670

  Higashimoto, Yuki ^a,b   Ihira, Masaru ^a   Ohta, Akane ^a   Inoue, Shigeki ^a   Usui, Chie ^b   Asano, Yoshizo ^a,b   Yoshikawa, Tetsushi ^a,b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE; VIRUS DNA; CCCGGG SPECIFIC TYPE II DEOXYRIBONUCLEASES; CCCGGG-SPECIFIC TYPE II DEOXYRIBONUCLEASES; CCGCGG SPECIFIC TYPE II DEOXYRIBONUCLEASES; CCGCGG-SPECIFIC TYPE II DEOXYRIBONUCLEASES; CHICKENPOX VACCINE; IE62 PROTEIN, HUMAN HERPESVIRUS 3; IMMEDIATE EARLY PROTEIN; PRIMER DNA; TRANSACTIVATOR PROTEIN; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; VIRUS ENVELOPE PROTEIN;

AGAR GEL ELECTROPHORESIS; ARTICLE; DNA DETERMINATION; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE TARGETING; GENOTYPE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TURBIDITY; VARICELLA ZOSTER VIRUS; VIRUS STRAIN; WILD TYPE; CHICKENPOX; CLASSIFICATION; EVALUATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PHOTOMETRY; VIROLOGY;

HUMAN HERPESVIRUS 3;

BASE SEQUENCE; CHICKENPOX; CHICKENPOX VACCINE; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA PRIMERS; DNA, VIRAL; ELECTROPHORESIS, AGAR GEL; HERPESVIRUS 3, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; MOLECULAR SEQUENCE DATA; NEPHELOMETRY AND TURBIDIMETRY; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; TRANS-ACTIVATORS; VIRAL ENVELOPE PROTEINS;

EID: 53149134336     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00216-08     Document Type: Article

References (31)

1. Argaw, T., J. I. Cohen, M. Klutch, K. Lekstrom, T. Yoshikawa, Y. Asano, and P. R. Krause. 2000. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J. Infect. Dis. 181: 1153-1157.
2. Asano, Y., N. Itakura, Y. Hiroishi, S. Hirose, T. Ozaki, K. Kuno, T. Nagai, T. Yazaki, K. Yamanishi, and M. Takahashi. 1985. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J. Infect. Dis. 152:863-868.
3. Asano, Y. 1996. Varicella vaccine: the Japanese experience. J. Infect. Dis. 174:S310-S313.
4. Campsall, P. A., N. H. Au, J. S. Prendiville, D. P. Speert, R. Tan, and E. E. Thomas. 2004. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J. Clin. Microbiol. 42:1409-1413.
5. Enomoto, Y., T. Yoshikawa, M. Ihira, S. Akimoto, F. Miyake, C. Usui, S. Suga, K. Suzuki, T. Kawana, Y. Nishiyama, and Y. Asano. 2005. Rapid diagnosis of herpes simplex virus infection by a loop-mediated isothermal amplification method. J. Clin. Microbiol. 43:951-955.
6. Gershon, A. A. 1995. Varicella-zoster virus: Prospects for control. Adv. Pediatr. Infect. Dis. 10:93-124.
7. Gomi, Y., T. Imagawa, M. Takahashi, and K. Yamanishi. 2001. Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses. Arch. Virol. Suppl. 17:49-56.
8. Gomi, Y., H. Sunamachi, Y. Mori, K. Nagaike, M. Takahashi, and K. Yamanishi. 2002. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J. Virol. 76:11447-11459.
9. Grossberg, R., R. Harpaz, E. Rubtcova, V. Loparev, J. F. Seward, and D. S. Schmid. 2006. Secondary transmission of varicella vaccine virus in a chronic care facility for children. J. Pediatr. 148:842-844.
10. Hardy, I., A. A. Gershon, S. P. Steinberg, P. LaRussa, et al. 1991. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N. Engl. J. Med. 325:1545-1550.
11. Ihira, M., T. Yoshikawa, Y. Enomoto, S. Akimoto, M. Ohashi, S. Suga, N. Nishimura, T. Ozaki, Y. Nishiyama, T. Notomi, Y. Ohta, and Y. Asano. 2004. Rapid diagnosis of human herpesvirus 6 infection by a novel DNA amplification method, loop-mediated isothermal amplification. J. Clin. Microbiol. 42:140-145.
12. Ihira, M., S. Akimoto, F. Miyake, A. Fujita, K. Sugata, S. Suga, M. Ohashi, N. Nishimura, T. Ozaki, Y. Asano, and T. Yoshikawa. 2007. Direct detection of human herpesvirus 6 DNA in serum by the loop-mediated isothermal amplification method. J. Clin. Virol. 39:22-26.
13. Kimura, H., S. Kido, T. Ozaki, N. Tanaka, Y. Ito, R. K. Williams, and T. Morishima. 2000. Comparison of quantitations of viral load in varicella and zoster. J. Clin. Microbiol. 38:2447-2449.
14. Krause, P. R., and D. M. Klinman. 1995. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J. Pediatr. 127:518-525.
15. LaRussa, P., O. Lungu, I. Hardy, A. Gershon, S. P. Steinberg, and S. Silverstein. 1992. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J. Virol. 66:1016-1020.
16. Lässker, U., T. C. Harder, M. Hufnagel, and M. Suttorp. 2002. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus. Infection 30:320-322.
17. Lawrence, R., A. A. Gershon, R. Holzman, and S. P. Steinberg. 1988. The risk of zoster after varicella vaccination in children with leukemia. N. Engl. J. Med. 318:543-548.
18. Loparev, V. N., A. Gonzalez, M. Deleon-Carnes, G. Tipples, H. Fickenscher, E. G. Torfason, and D. S. Schmid. 2004. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J. Virol. 78:8349-8358.
19. Loparev, V. N., E. Rubtcova, J. F. Seward, M. J. Levin, and D. S. Schmid. 2007. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J. Infect. Dis. 195:502-510.
20. Macaladad, N., T. Marcano, M. Guzman, J. Moya, F. Jurado, M. Thompson, C. Meechan, D. Li, K. Schlienger, I. Chan, J. Sadoff, F. Schödel, and J. L. Silber. 2007. Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults. Vaccine 25:2139-2144.
21. Notomi, T., H. Okayama, H. Masubuchi, T. Yonekawa, K. Watanabe, N. Amino, and T. Hase. 2000. Loop mediated isothermal amplification of DNA. Nucleic Acids Res. 28:e63.
22. Okamoto, S., T. Yoshikawa, M. Ihira, K. Suzuki, K. Shimokata, Y. Nishiyama, and Y. Asano. 2004. Rapid detection of varicella-zoster virus infection by a loop-mediated isothermal amplification method. J. Med. Virol. 74:677-682.
23. Oxman, M. N., M. J. Levin, G. R. Johnson, K. E. Schmader, S. E. Straus, L. D. Gelb, R. D. Arbeit, M. S. Simberkoff, A. A. Gershon, L. E. Davis, A. Weinberg, K. D. Boardman, H. M. Williams, J. H. Zhang, P. N. Peduzzi, C. E. Beisel, V. A. Morrison, J. C. Guatelli, P. A. Brooks, C. A. Kauffman, C. T. Pachucki, K. M. Neuzil, R. F. Betts, P. F. Wright, M. R. Griffin, P. Brunell, N. E. Soto, A. R. Marques, S. K. Keay, R. P. Goodman, D. J. Cotton, J. W. Gnann, Jr., J. Loutit, M. Holodniy, W. A. Keitel, G. E. Crawford, S. S. Yeh, Z. Lobo, J. F. Toney, R. N. Greenberg, P. M. Keller, R. Harbecke, A. R. Hayward, M. R. Irwin, T. C. Kyriakides, C. Y. Chan, I. S. Chan, W. W. Wang, P. W. Annunziato, and J. L. Silber. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352:2271-2284.
24. Parker, S. P., M. Quinlivan, Y. Taha, and J. Breuer. 2006. Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J. Clin. Microbiol. 44:3911-3914.
25. Quinlivan, M., A. A. Gershon, S. P. Steinberg, and J. Breuer. 2005. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus. J. Med. Virol. 75:174-180.
26. Sharrar, R. G., P. LaRussa, S. A. Galea, S. P. Steinberg, A. R. Sweet, R. M. Keatley, M. E. Wells, W. P. Stephenson, and A. A. Gershon. 2000. The postmarketing safety profile of varicella vaccine. Vaccine 19:916-923.
27. Suzuki, R., T. Yoshikawa, M. Ihira, Y. Enomoto, S. Inagaki, K. Matsumoto, K. Kato, K. Kudo, S. Kojima, and Y. Asano. 2006. Development of the loop-mediated isothermal amplification method for rapid detection of cytomegalovirus DNA. J. Virol. Methods 132:216-221.
28. Takahashi, M., Y. Okuno, T. Otsuka, J. Osame, and A. Takamizawa. 1975. Development of a live attenuated varicella vaccine. Biken J. 18:25-33.
29. Tang, Y. W., H. T. Allawi, M. DeLeon-Carnes, H. Li, S. P. Day, and D. S. Schmid. 2007. Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method. J. Clin. Virol. 40:129-134.
30. Tyring, S. K., F. Diaz-Mitoma, L. G. Padget, M. Nunez, G. Poland, W. M. Cassidy, N. D. Bundick, J. Li, I. S. Chan, J. E. Stek, and P. W. Annunziato. 2007. Safety and tolerability of a high-potency zoster vaccine in adults ≥50 years of age. Vaccine 25:1877-1883.
31. Yoshikawa, T., M. Ihira, S. Akimoto, C. Usui, F. Miyake, S. Suga, Y. Enomoto, R. Suzuki, Y. Nishiyama, and Y. Asano. 2004. Detection of human herpesvirus 7 DNA by loop-mediated isothermal amplification. J. Clin. Microbiol. 42:1348-1352.